Compass Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation

Vigeo Therapeutics Inc, based in Cambridge, MA, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for various types of cancer to enhance patient outcomes. Their focus lies in reprogramming the tumor immune microenvironment (TIME) through the activation of thrombospondin-1 (Tsp-1), a natural anti-tumorigenic protein that combats cancer cells and inhibits metastasis. Currently, Vigeo is conducting clinical trials for VT1021, a peptide therapeutic agent, in patients with pancreatic, ovarian, triple negative breast cancers, glioblastoma, and tumors with elevated levels of CD36. Their mission is to revolutionize cancer treatment by harnessing the body's own defenses against cancer and improving the lives of those affected by the disease.Generated from the website

Idenix Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, focused on developing innovative treatments for infectious diseases. The company's research and development efforts are dedicated to addressing unmet medical needs and improving patient outcomes. With a team of dedicated scientists and researchers, Idenix Pharmaceuticals is committed to advancing cutting-edge therapies that have the potential to make a significant impact in the field of infectious disease treatment. The company's mission is to deliver safe and effective treatments that have the potential to transform the lives of patients worldwide. Generated from their business information